Paper38643239
A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease.
Li HY and 9 others. Commun Chem, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease. Papers, record 38643239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38643239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8611585 | Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors. | Biochemistry | 1996 | https://conductscience.org/library/papers/8611585 | PubMed |
| 2 | 18328804 | Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase. | Biochem Biophys Res Commun | 2008 | https://conductscience.org/library/papers/18328804 | PubMed |
| 3 | 14533157 | Rapid diversity-oriented synthesis in microtiter plates for in situ screening: discovery of potent and selective alpha-fucosidase inhibitors. | Angew Chem Int Ed Engl | 2003 | https://conductscience.org/library/papers/14533157 | PubMed |
| 4 | 22308055 | Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery? | Angew Chem Int Ed Engl | 2012 | https://conductscience.org/library/papers/22308055 | PubMed |
| 5 | 16945909 | The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16945909 | PubMed |
| 6 | 27063389 | Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201C. | Carbohydr Res | 2016 | https://conductscience.org/library/papers/27063389 | PubMed |
| 7 | 16231389 | Rational design and synthesis of highly potent beta-glucocerebrosidase inhibitors. | Angew Chem Int Ed Engl | 2005 | https://conductscience.org/library/papers/16231389 | PubMed |
| 8 | 16397876 | Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis. | Chembiochem | 2006 | https://conductscience.org/library/papers/16397876 | PubMed |
| 9 | 29719681 | Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones. | Chem Sci | 2018 | https://conductscience.org/library/papers/29719681 | PubMed |
| 10 | 23943613 | From natural product-inspired pyrrolidine scaffolds to the development of new human Golgi α-mannosidase II inhibitors. | Chem Asian J | 2013 | https://conductscience.org/library/papers/23943613 | PubMed |
| 11 | 21751327 | Synthesis, kinetic evaluation and cell-based analysis of C-alkylated isofagomines as chaperones of β-glucocerebrosidase. | Chembiochem | 2011 | https://conductscience.org/library/papers/21751327 | PubMed |
| 12 | 32899288 | Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and C-5a-Substituted Derivatives of 4-epi-Isofagomine. | Molecules | 2020 | https://conductscience.org/library/papers/32899288 | PubMed |
| 13 | 28265599 | Screening methods for identifying pharmacological chaperones. | Mol Biosyst | 2017 | https://conductscience.org/library/papers/28265599 | PubMed |
| 14 | 25688781 | Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial. | JAMA | 2015 | https://conductscience.org/library/papers/25688781 | PubMed |
| 15 | 35733906 | Harnessing natural-product-inspired combinatorial chemistry and computation-guided synthesis to develop N-glycan modulators as anticancer agents. | Chem Sci | 2022 | https://conductscience.org/library/papers/35733906 | PubMed |
| 16 | 35535638 | Synthesis of Nitrone-derived Pyrrolidine Scaffolds and Their Combinatorial Libraries to Develop Selective α-l-Rhamnosidase Inhibitors. | Chem Asian J | 2022 | https://conductscience.org/library/papers/35535638 | PubMed |
| 17 | 29289886 | Synthesis of (3S,4S,5S)-trihydroxylpiperidine derivatives as enzyme stabilizers to improve therapeutic enzyme activity in Fabry patient cell lines. | Eur J Med Chem | 2018 | https://conductscience.org/library/papers/29289886 | PubMed |
| 18 | 9157194 | Fagomine isomers and glycosides from Xanthocercis zambesiaca. | J Nat Prod | 1997 | https://conductscience.org/library/papers/9157194 | PubMed |
| 19 | 27043200 | Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases. | Chem Commun (Camb) | 2016 | https://conductscience.org/library/papers/27043200 | PubMed |
| 20 | 17187079 | Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease. | Nat Chem Biol | 2007 | https://conductscience.org/library/papers/17187079 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42915455 | Prism[5]arene Iminosugar Bioconjugates Are Potent Multivalent Inhibitors and Mutation Specific Pharmacological Chaperones of Glucocerebrosidase (GCase) Activity. | Bioconjug Chem | 2026 | https://conductscience.org/library/papers/42915455 | PubMed |
| 42889562 | A pH-Dependent Curcumin-Iminosugar Hybrid Promotes GCase Enhancement and Reactive Oxygen Species Reduction. | ACS Omega | 2026 | https://conductscience.org/library/papers/42889562 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C5AR1 | 728 | PubTator's text mining | https://conductscience.org/library/genes/728 | NCBI Gene |
| GBA1 | 2629 | PubTator's text mining | https://conductscience.org/library/genes/2629 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38643239
GET https://conductscience.org/api/papers/v1/38643239/references?page=2